$1.92
+0.08 (+4.35%)
Open$1.90
Previous Close$1.84
Day High$1.99
Day Low$1.78
52W High$315.00
52W Low—
Volume—
Avg Volume46.1K
Market Cap1.83M
P/E Ratio—
EPS$-25.66
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 398.2K | 400.3K | 406.3K |
| Net Income | -29,112 | -35,289 | -31,464 |
| Profit Margin | -7.3% | -8.8% | -7.7% |
| EBITDA | -48,158 | -49,842 | -45,919 |
| Free Cash Flow | -34,661 | -49,903 | -42,011 |
| Rev Growth | +16.9% | +4.6% | -8.7% |
| Debt/Equity | 0.13 | 0.15 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |